Projects per year
Personal profile
Personal profile
Dr. Lee graduated with honors from the University of California at Berkeley where he also received the Eric Hoffer Essay Prize his senior year. From 1992 until 2001, he earned a M.D. and Ph.D. degrees from the Stanford University Medical School in Stanford, California. While there, Dr. Li was mentored under a Medical Scientist Training Program grant from the National Institute of General Medical Sciences. Dr. Lee is the first author on several key research papers, including one on histone acetylation that was published in Cell while he was still in medical school. Dr. Lee assumed his positions at Methodist in 2008.
Research interests
Dr. Lee is an accomplished expert in nuclear medicine, biophysics, and molecular biology. His research specifically centers on pathophysiology from a molecular imaging approach. He studies the epigenetics of cancer, and develops new tools for the study of biochemical and intracellular signaling pathways, as well as platform technology for targeted radiotherapy.
Education/Academic qualification
Nuclear Medicine, Residency, UCLA School of Medicine
Jul 1 2006 → Jul 31 2008
Award Date: Jul 31 2008
Internal Medicine, Internship, UCLA School of Medicine
Jul 1 2003 → Jul 31 2006
Award Date: Jul 31 2006
Radiology, Clinical Fellowship, Stanford School of Medicine
Jul 1 2001 → Jun 30 2003
Award Date: Jun 30 2003
MD, Stanford University
Sep 1 1992 → Jun 30 2001
Award Date: Jun 30 2001
Nuclear Medicine, Postdoctoral Fellowship, Department of Nuclear Medicine, University of California at Los Angeles
Molecular Imaging, Postdoctoral Fellowship, Stanford University
Biological Physics, PhD, Stanford University
Research Area Keywords
- Imaging & Radiology
Free-text keywords
- Cancer
- Nanoparticles
- Pathophysiology
- Radiotherapy
Fingerprint
Dive into the research topics where Daniel Y. Lee is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
TRACK-ALS
Masdeu, J. C. (PI), Appel, S. H. (CoI), Lee, D. Y. (CoI), Pascual, B. (CoI) & Yu, M. (CoI)
1/1/15 → 7/31/17
Project: Non Profit
-
Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study
Kim, W. S., Oki, Y., Kim, S. J., Yoon, S. E., Ardeshna, K. M., Lin, Y., Ruan, J., Porcu, P., Brammer, J. E., Jacobsen, E. D., Yoon, D. H., Suh, C., Suarez, F., Radford, J., Budde, L. E., Kim, J. S., Bachy, E., Lee, H. J., Bollard, C. M. & Jaccard, A. & 9 others, , Oct 2021, In: Annals of Hematology. 100, 10, p. 2529-2539 11 p.Research output: Contribution to journal › Article › peer-review
19 Scopus citations -
Cancer epigenomics and beyond: Advancing the precision oncology paradigm
Lee, D. Y., 2020, In: Journal of Immunotherapy and Precision Oncology. 3, 4, p. 147-156 10 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Tumor-specific t-cells engineered to overcome tumor immune evasion induce clinical responses in patients with relapsed hodgkin lymphoma
Bollard, C. M., Tripic, T., Cruz, C. R., Dotti, G., Gottschalk, S., Torrano, V., Dakhova, O., Carrum, G., Ramos, C. A., Liu, H., Wu, M. F., Marcogliese, A. N., Barese, C., Zu, Y., Lee, D. Y., O’Connor, O., Gee, A. P., Brenner, M., Heslop, H. & Rooney, C. M., Apr 10 2018, In: Journal of Clinical Oncology. 36, 11, p. 1128-1139 12 p.Research output: Contribution to journal › Article › peer-review
Open Access143 Scopus citations -
A tyrosine kinase inhibitor-based high-affinity PET radiopharmaceutical targets vascular endothelial growth factor receptor
Li, F., Jiang, S., Zu, Y., Lee, D. Y. & Li, Z., Sep 1 2014, In: Journal of Nuclear Medicine. 55, 9, p. 1525-1531 7 p.Research output: Contribution to journal › Article › peer-review
20 Scopus citations -
Current therapy and novel agents for relapsed or refractory acute lymphoblastic leukemia
Dinner, S., Lee, D. & Liedtke, M., Aug 2014, In: Leukemia and Lymphoma. 55, 8, p. 1715-1724 10 p.Research output: Contribution to journal › Review article › peer-review
26 Scopus citations